SB-237376 (freebase) is a potassium and calcium channel blocker that inhibits the rapidly activating delayed rectifier potassium current I(Kr) (IC50 = 0.42 μM) and, at higher concentrations, blocks L-type calcium current I(Ca,L). It induces early afterdepolarizations (EADs) at 3 μM in a rabbit ventricular model but exhibits a lower proarrhythmic risk compared to other I(Kr) inhibitors such as dl-sotalol. SB-237376 (freebase) shows potential for research in the field of arrhythmia-related diseases.